Skip to content

Transvaginal single port laparoscopic sacral fixation, high uterosacral ligament suspension and sacrospinous ligament fixation for the treatment of pelvic organ prolapse: a prospective randomized controlled study

Transvaginal single port laparoscopic sacral fixation, high uterosacral ligament suspension and sacrospinous ligament fixation for the treatment of pelvic organ prolapse: a prospective randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044868
Enrollment
Unknown
Registered
2021-03-30
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic organ prolapse

Interventions

Group A:transvaginal single port laparoscopic sacral fixation
Group B:transvaginal single port laparoscopic high uterosacral ligament suspension
Group C:sacrospinous ligament fixation

Sponsors

Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. From January 2021 to January 2022, cases of female pelvic organ prolapse are diagnosed and treated in the Obstetrics and Gynecology Hospital of Fudan University; 2. Patients who have informed consent and will sign the informed consent; 3. Adult female; 4. Patients with symptomatic pelvic prolapse and stage III or above of POP-Q, or recurrence of stage II with above of POP-Q; 5. Patients who can be followed up for 3 years.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of pelvic radiotherapy; 2. Patients with prolapse treated by transvaginal mesh; 3. Women with fertility requirements; pregnant or lactating patients; 4. The patients with pelvic pain caused by pelvic floor muscle spasm were found under basic condition; 5. Patients with long-term use of steroid hormone in immune diseases; 6. Current smokers; 7. Patients with pain syndrome, which may lead to increased sensitivity to pelvic pain (such as fibromyalgia, bladder pain syndrome); 8. Patients who may have malignant tumors; 9. Patients who are too old to tolerate surgery or whose surgical benefits are significantly smaller than surgical trauma.

Design outcomes

Primary

MeasureTime frame
POP-Q;the quality of life questionnare;

Secondary

MeasureTime frame
complications;recurrence;

Countries

China

Contacts

Public ContactYisong Chen

Obstetrics and Gynecology Hospital of Fudan University

cys373900207@qq.com+86 13601913713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026